Medicine and Dentistry
Prospective Study
100%
Neuroendocrine Tumor
100%
Positron Emission Tomography-Computed Tomography
100%
Copper 64
100%
Radioactive Tracer
100%
Gallium 68
100%
Positron Emission Tomography
33%
Single-Photon Emission Computed Tomography
33%
Computer Assisted Tomography
16%
Lymph Node
16%
Octreotide
16%
Somatostatin Receptor
16%
Radioisotope
16%
Diagnostic Performance
16%
False Positive Result
16%
Indium 111
16%
Treatment Planning
16%
Pentetic Acid
16%
Photon Emission Tomography
16%
Keyphrases
Neuroendocrine Tumor
100%
Head-to-head Comparison
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
DOTATATE
100%
64Cu-DOTATATE
100%
68Ga-DOTATOC
100%
Tumor Patients
33%
Gallium-68
25%
True Positive
16%
High Sensitivity
8%
Positron Emission Tomography
8%
Clinical Setting
8%
Single-photon Emission Computed Tomography (SPECT)
8%
Diagnostic Performance
8%
Octreotide
8%
Positron Emission Tomography Tracers
8%
Lymph Node
8%
Patient-centered
8%
Treatment Planning
8%
Radioisotopes
8%
Somatostatin Receptor Imaging
8%
SPECT Tracers
8%
Shelf Life
8%
Additional Lesion
8%
Scanning Window
8%